Page-2 of Topic: COVAXIN
World Immunisation Week
The World Immunisation Week is celebrated every year in the last week of April. It aims to promote the use of vaccines. This year, in 2021, the World...
Infections after COVID Vaccination
The Indian Council of Medical Research recently reported that around two to four of the ten thousand vaccinated people tested positive for the disease. This is referred to...
IndRa: Cost of vaccinating India’s population above 18 years 0.36% of GDP
The India Ratings and Research (Ind-Ra) recently said the estimated cost to vaccinate all the Indians of age 18 years will be Rs 67,193 crores. This is 0.36%...
COVAXIN neutralises double Mutant Strain
The Indian Council of Medical Research recently announced that COVAXIN neutralises the Double Mutant Strain of COVID-19. Key Highlights The National Institute of Virology recently demonstrated the neutralisation...
COVAXIN: Transfer of Technology from Bharat Biotech to Haffkine
The Government of India recently approved the transfer of technology from Bharat Biotech to Hafkine Institute. COVAXIN COVAXIN is one of the two drugs that is currently administered...
Why is GoI fast tracking the Emergency use of foreign made COVID-19 Vaccines?
The Government of India recently announced that it is speeding up the Emergency Usage Approvals of foreign made COVID-19 vaccines. This includes COVID-19 vaccines that have been granted...
India: Expert panel recommends approval to Sputnik V vaccine
An Expert panel of the Central Drugs Standard Control Organisation (CDSCO) recently approved the Emergency Use of COVID-19 vaccine Sputnik-V. However, the Drugs Controller General of India (DGCI)...
Tika Utsav: COVID-19 Vaccination Drive
The Prime Minister Narendra Modi recently appealed to the Chief Ministers of the States to organise “Tika Utsav”. What is Tika Utsav? Tika Utsav is a vaccine festival....
India approved two COVID-19 vaccines for Emergency Use
The Drug Controller General of India recently announced that it has authorised two COVID-19 vaccines for restricted Emergency Use in India. What are the two COVID-19 Vaccines approved...
SII’s Covishield gets emergency-use nod from DGCI
The Subject Expert committee that is advising the Drug Controller General of India (DCGI) recommended restricted Emergency Use Authorisation for COVISHIELD. COVISHIELD vaccine was developed by Serum Institute...
COVAXIN of Bharat Biotech enters Phase III trials: Largest COVID-19 clinical trial of India
On November 16, 2020 the Bharat Biotech announced the commencement of Phase III trials of COVAXIN vaccines in India. The trials will involve 26,000 volunteers. It is to... 